Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3157)
All Articles published online
|
Jun 15, 2003 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Wu GS, Zou SQ, Liu ZR, Tang ZH, Wang JH. Celecoxib inhibits proliferation and induces apoptosis |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i6/1302.htm |
| Number | Citing Articles |
| 1 |
Tina Kaczor. Naturopathy. Integrative Cancer Therapies 2006; 5(2): 140 doi: 10.1177/1534735406288658
|
| 2 |
Garry G. Graham, Kieran F. Scott. Limitations of drug concentrations used in cell culture studies for understanding clinical responses of NSAIDs. Inflammopharmacology 2021; 29(5): 1261 doi: 10.1007/s10787-021-00871-2
|
| 3 |
James F. Watkins, Matthew S. Mayo, Holly J. Smith, Stephen K. Williamson. Gemcitabine, irinotecan and celecoxib in patients with biliary cancer. Anti-Cancer Drugs 2009; 20(4): 294 doi: 10.1097/CAD.0b013e3283287ca0
|
| 4 |
Bahram Daraei, Gholamreza Karimi, Pouran Makhdoumi, Afshin Zarghi. Evaluation of Cytotoxicity Effects of Chalcone Epoxide Analogues as a Selective COX-II Inhibitor in the Human Liver Carcinoma Cell Line. Journal of Pharmacopuncture 2017; 20(3): 207 doi: 10.3831/KPI.2017.20.024
|
| 5 |
Michael A. Kern, Peter Schirmacher, Tobias Schilling, Martina Müller. Induction of Apoptosis by Celecoxib in Cell Culture: An Uncertain Role for Cyclooxygenase-2. Cancer Research 2007; 67(11): 5576 doi: 10.1158/0008-5472.CAN-07-0448
|
| 6 |
Jolanta Parada-Turska, Wojciech Rzeski, Wojciech Zgrajka, Maria Majdan, Martyna Kandefer-Szerszeń, Waldemar Turski. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatology International 2006; 26(5): 422 doi: 10.1007/s00296-005-0057-4
|
| 7 |
Deepika Dhawan, Antonella Borgatti Jeffreys, Rong Zheng, Jane C. Stewart, Deborah W. Knapp. Cyclooxygenase-2 dependent and independent antitumor effects induced by celecoxib in urinary bladder cancer cells. Molecular Cancer Therapeutics 2008; 7(4): 897 doi: 10.1158/1535-7163.MCT-07-0313
|
| 8 |
Tong Wu. Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2005; 1755(2): 135 doi: 10.1016/j.bbcan.2005.04.002
|
| 9 |
Kyoung-won Seo, Ye-rin Coh, Robert B. Rebhun, Jin-ok Ahn, Sei-Myung Han, Hee-woo Lee, Hwa-Young Youn. Antitumor effects of celecoxib in COX-2 expressing and non-expressing canine melanoma cell lines. Research in Veterinary Science 2014; 96(3): 482 doi: 10.1016/j.rvsc.2014.03.003
|
| 10 |
Alphonse E. Sirica. Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy. Hepatology 2005; 41(1): 5 doi: 10.1002/hep.20537
|
| 11 |
Weiying Li, Wentao Yue, Hui Wang, Baitang Lai, Xuehui Yang, Chunyan Zhang, Yue Wang, Meng Gu. Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer. Oncology Letters 2016; 12(5): 3836 doi: 10.3892/ol.2016.5207
|
| 12 |
Carlos Rosas, Mariana Sinning, Arturo Ferreira, Marcela Fuenzalida, David Lemus. Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapy. Biological Research 2014; 47(1) doi: 10.1186/0717-6287-47-27
|
| 13 |
Jesper B. Andersen. Molecular pathogenesis of intrahepatic cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2): 101 doi: 10.1002/jhbp.155
|
| 14 |
T. Naruse, Y. Nishida, N. Ishiguro. Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells. Biomedicine & Pharmacotherapy 2007; 61(6): 338 doi: 10.1016/j.biopha.2007.02.011
|
| 15 |
Antonio Buzharevski, Svetlana Paskaš, Menyhárt-Botond Sárosi, Markus Laube, Peter Lönnecke, Wilma Neumann, Blagoje Murganić, Sanja Mijatović, Danijelа Maksimović-Ivanić, Jens Pietzsch, Evamarie Hey-Hawkins. Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59059-3
|
| 16 |
Tong Wu, Jing Leng, Chang Han, Anthony Jake Demetris. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Molecular Cancer Therapeutics 2004; 3(3): 299 doi: 10.1158/1535-7163.299.3.3
|
| 17 |
Sandra Huguenin, Francis Vacherot, Laurence Kheuang, Jocelyne Fleury-Feith, Marie-Claude Jaurand, Manlio Bolla, Jean-Pierre Riffaud, Dominique K. Chopin. Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines. Molecular Cancer Therapeutics 2004; 3(3): 291 doi: 10.1158/1535-7163.291.3.3
|
| 18 |
Minami Sato, Shingo Kuroda, Karima Qurnia Mansjur, Ganzorig Khaliunaa, Kumiko Nagata, Shinya Horiuchi, Toshihiro Inubushi, Yoshiko Yamamura, Masayuki Azuma, Eiji Tanaka. Low-intensity pulsed ultrasound rescues insufficient salivary secretion in autoimmune sialadenitis. Arthritis Research & Therapy 2015; 17(1) doi: 10.1186/s13075-015-0798-8
|
| 19 |
Bo-Min Kim, Guen-Tae Kim, Eun-Ji Kim, Eun-Gyeong Lim, Sang-Yong Kim, Young-Min Kim. The Extract from Artemisia annua Linné. Induces p53-independent Apoptosis through Mitochondrial Signaling Pathway in A549 Lung Cancer Cells. Journal of Life Science 2016; 26(8): 887 doi: 10.5352/JLS.2016.26.8.887
|
| 20 |
Tatsuya Nakamura, Shinji Fujihara, Kumiko Yamamoto-Nagata, Tomoko Katsura, Toshihiro Inubushi, Eiji Tanaka. Low-Intensity Pulsed Ultrasound Reduces the Inflammatory Activity of Synovitis. Annals of Biomedical Engineering 2011; 39(12): 2964 doi: 10.1007/s10439-011-0408-0
|
| 21 |
Michiyo Senzaki, Saori Ishida, Ayumi Yada, Masaharu Hanai, Kosaku Fujiwara, Shin‐Ichi Inoue, Tomio Kimura, Shinichi Kurakata. CS‐706, a novel cyclooxygenase‐2 selective inhibitor, prolonged the survival of tumor‐bearing mice when treated alone or in combination with anti‐tumor chemotherapeutic agents. International Journal of Cancer 2008; 122(6): 1384 doi: 10.1002/ijc.23250
|
| 22 |
Kemal Kısmet, M.Turan Akay, Osman Abbasoǧlu, Aygün Ercan. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detection and Prevention 2004; 28(2): 127 doi: 10.1016/j.cdp.2003.12.005
|
| 23 |
Chen Chen, Dinghua Yang, Qinghua Zeng, Liang Luo, Chengzhi Cai. PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5967
|
| 24 |
David Malka, Valérie Boige, Clarisse Dromain, Thierry Debaere, Marc Pocard, Michel Ducreux. Biliary tract neoplasms: update 2003. Current Opinion in Oncology 2004; 16(4): 364 doi: 10.1097/01.cco.0000129679.49651.50
|
| 25 |
Takahiro Naruse, Yoshihiro Nishida, Kozo Hosono, Naoki Ishiguro. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis 2006; 27(3): 584 doi: 10.1093/carcin/bgi240
|
| 26 |
D Sia, V Tovar, A Moeini, J M Llovet. Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies. Oncogene 2013; 32(41): 4861 doi: 10.1038/onc.2012.617
|
| 27 |
JONG WON PARK, KYOUNG-JIN MIN, DONG EUN KIM, TAEG KYU KWON. Withaferin A induces apoptosis through the generation of thiol oxidation in human head and neck cancer cells. International Journal of Molecular Medicine 2015; 35(1): 247 doi: 10.3892/ijmm.2014.1983
|
| 28 |
Adrian Churchman, Anwar R. Baydoun, Richard Hoffman. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697). European Journal of Pharmacology 2007; 573(1-3): 176 doi: 10.1016/j.ejphar.2007.06.057
|
| 29 |
Minami Sato, Kumiko Nagata, Shingo Kuroda, Shinya Horiuchi, Tatsuya Nakamura, Mansjur Karima, Toshihiro Inubushi, Eiji Tanaka. Low-Intensity Pulsed Ultrasound Activates Integrin-Mediated Mechanotransduction Pathway in Synovial Cells. Annals of Biomedical Engineering 2014; 42(10): 2156 doi: 10.1007/s10439-014-1081-x
|
| 30 |
John H. Farley, Vu Truong, Elwin Goo, Catherine Uyehara, Christina Belnap, Wilma I. Larsen. A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia. Gynecologic Oncology 2006; 103(2): 425 doi: 10.1016/j.ygyno.2006.03.036
|
| 31 |
M. Spychalski, L. Dziki, A. Dziki. Chemoprevention of colorectal cancer – a new target needed?. Colorectal Disease 2007; 9(5): 397 doi: 10.1111/j.1463-1318.2006.01166.x
|
| 32 |
M J Grainge, J West, M Solaymani-Dodaran, G P Aithal, T R Card. The antecedents of biliary cancer: a primary care case–control study in the United Kingdom. British Journal of Cancer 2009; 100(1): 178 doi: 10.1038/sj.bjc.6604765
|
| 33 |
Li Gong, Caroline F. Thorn, Monica M. Bertagnolli, Tilo Grosser, Russ B. Altman, Teri E. Klein. Celecoxib pathways. Pharmacogenetics and Genomics 2012; 22(4): 310 doi: 10.1097/FPC.0b013e32834f94cb
|
| 34 |
Lalita Tanwar, Vivek Vaish, Sankar Nath Sanyal. Chemopreventive role of etoricoxib (MK-0663) in experimental colon cancer: induction of mitochondrial proapoptotic factors. European Journal of Cancer Prevention 2010; 19(4): 280 doi: 10.1097/CEJ.0b013e3283396470
|
| 35 |
Zichen Zhang, Guan-Hua Lai, Alphonse E. Sirica. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation. Hepatology 2004; 39(4): 1028 doi: 10.1002/hep.20143
|
| 36 |
Akihiko Tsuchida, Takao Itoi, Kazuhiko Kasuya, Mitsufumi Endo, Kenji Katsumata, Toshiaki Aoki, Minako Suzuki, Tatsuya Aoki. Inhibitory effect of meloxicam, a cyclooxygenase-2 inhibitor, on N -nitrosobis (2-oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters. Carcinogenesis 2005; 26(11): 1922 doi: 10.1093/carcin/bgi149
|
| 37 |
Jesper B Andersen, Snorri S Thorgeirsson. A perspective on molecular therapy in cholangiocarcinoma: present status and future directions. Hepatic Oncology 2014; 1(1): 143 doi: 10.2217/hep.13.4
|